Correlation Between BICO Group and Bone Biologics

Can any of the company-specific risk be diversified away by investing in both BICO Group and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BICO Group and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BICO Group AB and Bone Biologics Corp, you can compare the effects of market volatilities on BICO Group and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BICO Group with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BICO Group and Bone Biologics.

Diversification Opportunities for BICO Group and Bone Biologics

0.7

Correlation Coefficient

BICO Group  Bone Biologics

Poor diversification

The 3 months correlation between BICO and Bone is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding BICO Group AB and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and BICO Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BICO Group AB are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of BICO Group i.e., BICO Group and Bone Biologics go up and down completely randomly.

Pair Corralation between BICO Group and Bone Biologics

Assuming the 90 days horizon BICO Group AB is expected to under-perform the Bone Biologics. But the pink sheet apears to be less risky and, when comparing its historical volatility, BICO Group AB is 6.85 times less risky than Bone Biologics. The pink sheet trades about -0.06 of its potential returns per unit of risk. The Bone Biologics Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  6,050  in Bone Biologics Corp on September 5, 2024 and sell it today you would lose (3,270) from holding Bone Biologics Corp or give up 54.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

BICO Group AB  vs.  Bone Biologics Corp

BICO Group AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BICO Group AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Bone Biologics Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BICO Group and Bone Biologics

The main advantage of trading using opposite BICO Group and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BICO Group position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.

The idea behind BICO Group AB and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.